Detection and characterization DNA adducts generated by tobacco flavorants in aerosol using ALI
Ended Awarded Last action
- Contract number
- HHSF22301007T
- Awardee
-
Lovelace Biomedical And Environmental Research Institute, Inc. UEI N1UBCLRAPNG6 Part of Lovelace Biomedical Research Institute
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $1,408,956
Award facts
- Opportunity
-
- 900000000 Solicitation number
- Contract value 100% obligated
- $1,408,956.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Albuquerque, NM 87108, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,408,956 |
About this award
This is a firm fixed-price delivery order issued by the Department of Health and Human Services Food and Drug Administration under the In Vivo Toxicology of Tobacco 2015-2020 indefinite delivery/indefinite quantity (IDIQ) contract. The $1,408,956.00 task order was awarded to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a not-for-profit contract research organization, to perform detection and characterization of DNA adducts generated by tobacco flavorants in aerosol using air-liquid interface (ALI) methods. This research supports the FDA's regulatory oversight of tobacco products. The parent organization, Lovelace Biomedical Research Institute, has extensive experience conducting preclinical research and testing services for government agencies such as NIH, BARDA, and DoD. The task order did not have a set-aside designation.
Quick answers
Who was awarded contract HHSF22301007T?
HHSF22301007T was awarded to Lovelace Biomedical And Environmental Research Institute, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 14, 2017.
How much is contract HHSF22301007T worth?
The government has obligated $1,408,956 on HHSF22301007T.
Is contract HHSF22301007T an order under another contract?
Yes. HHSF22301007T is a delivery order under HHSF223201510001I, an indefinite delivery contract, on In Vivo Toxicology of Tobacco 2015-2020.
Was contract HHSF22301007T competed?
The extent of competition for HHSF22301007T was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award